Advisory Board October 1, 2024
The Biden administration last week announced that average monthly Medicare drug premiums would decrease in 2025, largely due to a new plan providing billions of dollars in subsidies for insurers. However, several Republican lawmakers have sharply criticized the plan, saying that it “employs arbitrary policy levers to achieve short-term objectives.”
The 6 trends shaping pharma strategies for 2024
Stabilized Medicare drug premiums
The Inflation Reduction Act (IRA) includes several measures to reduce drug costs, including an out-of-pocket prescription drug spending cap of $2,000 for Medicare beneficiaries. However, these changes could significantly increase people’s premiums, costing them hundreds of dollars more a year.
To help stabilize Medicare drug premiums, federal health officials set up a demonstration that offered private insurers subsidies...
Today's Sponsors
Today's Sponsor